Millennium Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Millennium Management’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,123	Closed	-$192K	–	6443
2025 Q4	$192K	Sell	23,123 -48,867	-68%	-$271K	﹤0.01%	5485
2025 Q3	$310K	Sell	71,990 -18,718	-21%	-$113K	﹤0.01%	5324
2025 Q2	$481K	Buy	90,708 +51,143	+129%	+$275K	﹤0.01%	4941
2025 Q1	$175K	Buy	+39,565	New	+$256K	﹤0.01%	5337
2024 Q4	–	Sell	-2,003	Closed	-$29K	–	6503
2024 Q3	$29K	Buy	+2,003	New	+$90.2K	﹤0.01%	5752
2023 Q4	–	Sell	-2,832	Closed	-$110K	–	6591
2023 Q3	$110K	Sell	2,832 -23,229	-89%	-$1.18M	﹤0.01%	5312
2023 Q2	$1.5M	Buy	26,061 +8,240	+46%	+$500K	﹤0.01%	3717
2023 Q1	$1.16M	Sell	17,821 -2,724	-13%	-$165K	﹤0.01%	3955
2022 Q4	$565K	Buy	20,545 +13,138	+177%	+$351K	﹤0.01%	4653
2022 Q3	$216K	Sell	7,407 -5,966	-45%	-$204K	﹤0.01%	5613
2022 Q2	$257K	Buy	13,373 +3,602	+37%	+$181K	﹤0.01%	5489
2022 Q1	$792K	Buy	9,771 +349	+4%	+$28.8K	﹤0.01%	4753
2021 Q4	$863K	Buy	9,422 +7,759	+467%	+$879K	﹤0.01%	4538
2021 Q3	$208K	Sell	1,663 -30,292	-95%	-$3.4M	﹤0.01%	6092
2021 Q2	$3.61M	Buy	31,955 +28,613	+856%	+$3.47M	﹤0.01%	3192
2021 Q1	$506K	Sell	3,342 -30,190	-90%	-$4.18M	﹤0.01%	4821
2020 Q4	$3.86M	Sell	33,532 -2,765	-8%	-$254K	﹤0.01%	2696
2020 Q3	$2.81K	Buy	+36,297	New	+$2.97M	﹤0.01%	2332
2018 Q3	–	Sell	-2,575	Closed	-$508K	–	4307
2018 Q2	$508K	Buy	+2,575	New	+$504K	﹤0.01%	3158

Other funds holding VRCA

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management's VRCA Position: Q1 2026 in Review

Millennium Management sold out of Verrica Pharmaceuticals (VRCA) in Q1 2026, closing a stake of 23,123 shares — an estimated $192K sold.

Millennium Management first reported a position in VRCA in Q2 2018 and held it in 19 quarters. The position peaked at $3.86M in Q4 2020. 39 funds tracked by Wall St. Rank hold VRCA as of Q1 2026.

Millennium Management reported no remaining Verrica Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Millennium Management sold 23,123 Verrica Pharmaceuticals shares in Q1 2026, an estimated $192K.
Millennium Management first reported a position in Verrica Pharmaceuticals in Q2 2018 and held it in 19 quarters.
Millennium Management's Verrica Pharmaceuticals position peaked at $3.86M in Q4 2020.
39 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.